Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGF.
- DOI
- 10.1186/s12885-022-09335-4
- Published
- 2022 Mar 9
- Container
- BMC cancer
- Publisher
- figshare
- Open access
- yes
Credibility signals
uncertain Score 61/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-022-09335-4,
title = {Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGF.},
author = {Ebert K and Haffner I and Zwingenberger G and Keller S and Raimúndez E and Geffers R and Wirtz R and Barbaria E and Hollerieth V and Arnold R and Walch A and Hasenauer J and Maier D and Lordick F and Luber B},
year = {2022},
journal = {BMC cancer},
doi = {10.1186/s12885-022-09335-4},
url = {https://doi.org/10.1186/s12885-022-09335-4}
}RIS
TY - JOUR TI - Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGF. AU - Ebert K AU - Haffner I AU - Zwingenberger G AU - Keller S AU - Raimúndez E AU - Geffers R AU - Wirtz R AU - Barbaria E AU - Hollerieth V AU - Arnold R AU - Walch A AU - Hasenauer J AU - Maier D AU - Lordick F AU - Luber B PY - 2022 JO - BMC cancer DO - 10.1186/s12885-022-09335-4 UR - https://doi.org/10.1186/s12885-022-09335-4 ER -
APA
K, E., I, H., G, Z., S, K., E, R., R, G., R, W., E, B., V, H., R, A., A, W., J, H., D, M., F, L., & B, L. (2022). Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies-the role of HAS2, SHB and HBEGF.. BMC cancer. https://doi.org/10.1186/s12885-022-09335-4
Source records
- pubmed · retrieved 2026-09-26T13:02:40.763Z
- europe-pmc · retrieved 2026-09-26T13:02:40.759Z
- datacite · retrieved 2026-09-26T13:02:40.735Z
- datacite · retrieved 2026-09-26T13:02:40.735Z
- doaj · retrieved 2026-09-26T13:02:40.737Z